Clinitech Laboratory Limited shareholders approved all three resolutions passed at the company's 16th Annual General Meeting held on September 24, 2026. The meeting, conducted via Video Conferencing, saw unanimous support for the adoption of FY26 financials and director re-appointment.

The proceedings were chaired by Jagdish Umakant Nayak, Chairman and Managing Director. For Agenda No. 3, involving related-party transactions under Section 185 of the Companies Act, 2013, Smita Patil, Independent Director, presided to manage interest conflicts within the promoter group. The Company Secretary, Shruti Patankar, confirmed that no proxy facility was available for this virtual meeting.

Voting results and scrutinizer's report

The scrutinizer, M/s Deep Shukla & Associates, reported that all resolutions were duly approved by members. Voting was conducted electronically through remote e-voting and live e-voting during the AGM. The remote voting window opened on September 21, 2026, and closed on September 23, 2026. Members holding shares as of the cut-off date, September 17, 2026, were eligible to vote.

For the ordinary resolutions regarding the adoption of standalone and consolidated audited financial statements for FY26 and the re-appointment of Ashutosh Jagdish Nayak as a director liable to retire by rotation, 1,613,900 votes were cast in favour. This represented 100% of the valid votes polled for these items. No votes were cast against these resolutions.

The special resolution approving transactions under Section 185 with persons in which directors are interested received 206,700 votes in favour, also representing 100% of valid votes. Notably, three members casting 1,407,200 votes had their ballots declared invalid for this specific item, likely due to regulatory restrictions on interested parties voting on such matters.

Participation details

The total number of shareholders on record was 271. No shareholders attended in person or through proxy. Eight shareholders participated through Video Conferencing, comprising four from the Promoter & Promoter Group and four Public Shareholders.

Meeting conclusion

No queries or questions were received from members prior to or during the meeting. The AGM concluded at 12:00 pm with a vote of thanks to the members, directors, auditors, and other attendees. The statutory auditors, M/s Kale Malde and Co, and the secretarial auditor, Deep Shukla & Associates, were present during the session. The consolidated results have been disseminated to the BSE and uploaded on the company's website.

Clinitech Laboratory Limited has scheduled its 16th Annual General Meeting (AGM) for Thursday, September 24, 2026, at 11:30 am via video conferencing. The Board of Directors approved the FY26 board report and finalized the meeting logistics on August 17, 2026.

The primary outcome of the recent gathering was the adoption of the Board’s report along with all associated annexures for the financial year 2025-26. This approval enables the company to issue the official notice for the 16th AGM, which now includes the determined date, time, and venue for the shareholder assembly. The Board also finalized the book closure dates necessary for determining eligible shareholders for the vote.

Key Agenda Items and Outcomes

In addition to financial approvals, the Board addressed succession planning by considering and approving the appointment of a director retiring by rotation. This standard governance procedure ensures continuity in leadership while adhering to statutory requirements for director tenure. To ensure transparency in the voting process, the Board finalized the appointment of Mr. Deep Shukla, a Practising Company Secretary, as the scrutinizer. His role will be to oversee the voting mechanism during the AGM, ensuring fairness and compliance with regulatory standards.

E-Voting and Book Closure Details

The Registrar of Members and Share Transfer Books will remain closed from Friday, September 18, 2026, to Thursday, September 24, 2026, both days inclusive. This period determines the list of eligible shareholders for the meeting.

Shareholders wishing to vote electronically must note that the cut-off date for e-voting is Thursday, September 17, 2026. The e-voting window will be open from Monday, September 21, 2026, at 9:00 am to Wednesday, September 23, 2026, at 5:00 pm.

The intimation regarding this meeting was initially issued on August 12, 2026, pursuant to Regulation 29 and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Jagdish Umakant Nayak, Chairman and Managing Director, signed the communication confirming the outcomes. A subsequent filing dated August 22, 2026, provided the specific e-voting timeline under Regulation 42 of the SEBI LODR Regulations. The company also published newspaper advertisements in Financial Express and Vritamanas on August 24, 2026, pursuant to Regulation 30.

Governance Compliance

The proceedings align with mandatory disclosure norms under the SEBI LODR framework. By scheduling the meeting through video conferencing, the company adheres to contemporary corporate governance practices that allow for flexible yet secure decision-making processes. The appointment of an independent scrutinizer further reinforces the integrity of the forthcoming AGM voting process.